145 related articles for article (PubMed ID: 34991292)
1. [Successful Re-Administration of Nivolumab in Patient with Metastatic Renal Cell Carcinoma : A Case Report].
Sasagawa H; Numakura K; Nakamura G; Kukimoto T; Kikuchi A; Sagehashi R; Yamamoto R; Koizumi A; Nara T; Kanda S; Saito M; Narita S; Inoue T; Satoh S; Habuchi T
Hinyokika Kiyo; 2021 Dec; 67(12):525-528. PubMed ID: 34991292
[TBL] [Abstract][Full Text] [Related]
2. [A CASE OF RENAL CELL CARCINOMA THAT ONCE NIVOLUMAB HAD BEEN EFFECTIVE IN METASTATIC LESION AND MADE PRIMARY TUMOR RESECTABLE].
Tsukahara S; Nagatomi Y; Otsubo S; Hasegawa S
Nihon Hinyokika Gakkai Zasshi; 2019; 110(1):32-35. PubMed ID: 31956216
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Myocardial Metastasis of Renal Cell Cancer Treated with Nivolumab].
Asakura T; Nakai Y; Oka T; Okuda Y; Hatano K; Nakayama M; Kakimoto K; Nishimura K
Hinyokika Kiyo; 2020 Jul; 66(7):225-228. PubMed ID: 32723977
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Renal Cell Carcinoma with Malignant Pleural Effusion Showing Marked Response to Axitinib].
Ishizuya Y; Okusa T; Hatano K; Nakai Y; Nakayama M; Kakimoto KI; Nishimura K
Hinyokika Kiyo; 2016 Oct; 62(10):525-528. PubMed ID: 27919126
[TBL] [Abstract][Full Text] [Related]
5. [METASTATIC Mucinous Tubular and Spindle Cell Carcinoma Treated with Nivolumab Successfully : A Case Report].
Takahashi Y; Numakura K; Aoyama Y; Okada S; Saito T; Muto Y; Koizumi A; Nara T; Chiba S; Kanda S; Saito M; Narita S; Inoue T; Satoh S; Nanjo H; Habuchi T
Hinyokika Kiyo; 2019 Sep; 65(9):363-367. PubMed ID: 31697878
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy.
Yoshida K; Takagi T; Kondo T; Kobayashi H; Iizuka J; Fukuda H; Ishihara H; Okumi M; Ishida H; Tanabe K
Jpn J Clin Oncol; 2019 Jun; 49(6):576-580. PubMed ID: 30924496
[TBL] [Abstract][Full Text] [Related]
7. [Complete Remission of Metastatic Renal Cell Carcinoma with Invasion of the Duodenum and Pancreas after Treatment with Nivolumab Plus Ipilimumab Followed by Axitinib and Surgery : A Case Report].
Hagimoto H; Yamazaki T; Kashima S; Yoshino T; Goto T; Sano T; Sawada A; Akamatsu S; Kobayashi T; Nakano K; Yagi S; Matsuoka Y; Fujimoto M; Kitamura T; Ogawa O
Hinyokika Kiyo; 2021 May; 67(5):197-203. PubMed ID: 34126663
[TBL] [Abstract][Full Text] [Related]
8. Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
Koie T; Ohyama C; Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y
BMC Res Notes; 2013 Nov; 6():484. PubMed ID: 24267160
[TBL] [Abstract][Full Text] [Related]
9. Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report.
Murata M; Ikeda Y; Hasegawa G; Nakagawa Y; Nishiyama T
J Med Case Rep; 2019 Apr; 13(1):98. PubMed ID: 31006385
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Rheumatoid Arthritis Developed during Treatment with Nivolumab for Renal Cell Carcinoma].
Tomizawa M; Nakai Y; Maesaka F; Owari T; Hara R; Miyake M; Inoue T; Anai S; Tanaka N; Fujimoto K
Hinyokika Kiyo; 2018 Oct; 64(10):397-401. PubMed ID: 30543737
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of Pembrolizumab Plus Axitinib Vs Nivolumab Plus Ipilimumab as First-Line Treatment of Advanced Renal Cell Carcinoma in the US.
Watson TR; Gao X; Reynolds KL; Kong CY
JAMA Netw Open; 2020 Oct; 3(10):e2016144. PubMed ID: 33052401
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular dysfunction associated with axitinib and nivolumab experience in an advanced renal cell carcinoma.
Tanriverdi O; Ates S; Sandal KK; Uylas S; Bosna IC; Alkan A
J Oncol Pharm Pract; 2020 Oct; 26(7):1765-1768. PubMed ID: 32164490
[TBL] [Abstract][Full Text] [Related]
13. Re-Challenging with Nivolumab in Metastatic Renal Cell Carcinoma After Immune-Related Interstitial Pneumonia: A Case Report.
Shibata Y; Noguchi G; Suzuki T; Osaka K; Umemoto S; Kishida T
Am J Case Rep; 2021 Aug; 22():e932924. PubMed ID: 34358221
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Pericardial Effusion Induced by Nivolumab for Metastatic Renal Cell Carcinoma].
Fukae S; Tanaka R; Yoshinaga M; Kawamura N; Nakagawa M; Tanigawa G; Tsutahara K; Takao T; Yamaguchi S
Hinyokika Kiyo; 2019 Aug; 65(8):329-332. PubMed ID: 31501401
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Axitinib After Nivolumab Failure in Metastatic Renal Cell Carcinoma.
Ishihara H; Takagi T; Kondo T; Fukuda H; Tachibana H; Yoshida K; Iizuka J; Okumi M; Ishida H; Tanabe K
In Vivo; 2020; 34(3):1541-1546. PubMed ID: 32354960
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Stauffer Syndrome-Like Findings Associated with Metastatic Renal Cell Cancer Improved by Molecular Targeted Therapy].
Ito K; Takamori H; Akioka T; Hida T; Okabe K; Kida K; Terada N; Kamimura T; Mukai S; Kamoto T
Hinyokika Kiyo; 2021 Jul; 67(7):309-312. PubMed ID: 34353011
[TBL] [Abstract][Full Text] [Related]
17. Case of complete response to neoadjuvant therapy using nivolumab in a patient with metastatic renal cell carcinoma.
Ikarashi D; Kato Y; Katagiri H; Takahara T; Uesugi N; Shiomi E; Sugimura J; Nitta H; Sugai T; Obara W
Int J Urol; 2018 Jun; 25(6):630-632. PubMed ID: 29693280
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma].
Hattahara K; Yamasaki T; Sawada A; Tanigaki K; Endo S; Teramoto Y; Banno H; Fuchigami Y; Suzuki R; Fujiwara M; Hida T; Yoshino T; Kita Y; Goto T; Akamatsu S; Saito R; Kobayashi T; Inoue T; Ogawa O
Hinyokika Kiyo; 2019 May; 65(5):157-161. PubMed ID: 31247693
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of second-line treatment following prior targeted therapy in patients with metastatic renal cell carcinoma: a comparison of axitinib and nivolumab.
Suzuki K; Terakawa T; Furukawa J; Harada K; Hinata N; Nakano Y; Fujisawa M
Int J Clin Oncol; 2020 Sep; 25(9):1678-1686. PubMed ID: 32488547
[TBL] [Abstract][Full Text] [Related]
20. [RENAL CELL CARCINOMA METASTASIS TO BLADDER DURING MOLECULAR TARGETED THERAPY WITH PAZOPANIB: REPORT OF TWO CASES].
Maruo K; Takahashi A; Tabata H; Takayanagi A; Takagi Y
Nihon Hinyokika Gakkai Zasshi; 2020; 111(2):58-61. PubMed ID: 33883361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]